Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Robert Nelsen

Affiliations

  • Large Shareholder, Director at Denali Therapeutics Inc. (DNI), 2019-08-13
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2019-07-17
  • Large Shareholder, Director at Karuna Therapeutics Inc. (KRTX), 2019-07-02
  • Large Shareholder, Director at Unity Biotechnology Inc. (UBX), 2019-06-24
  • Large Shareholder at Homology Medicines Inc. (FIXX), 2019-05-23
  • Large Shareholder at Sienna Biopharmaceuticals Inc. (SNNA), 2019-02-27
  • Large Shareholder at Gossamer Bio Inc. (GOSS), 2019-02-12
  • Large Shareholder at Twist Bioscience Corp (TWST), 2018-11-06
  • Large Shareholder at Scholar Rock Holding Corp (SRRK), 2018-06-01
  • Other at Pulmatrix Inc. (PULM), 2018-04-12
  • Director at Juno Therapeutics Inc. (JUNO), 2018-03-07
  • Large Shareholder at Quanterix Corp (QTRX), 2017-12-13
  • Director at Agios Pharmaceuticals Inc (AGIO), 2017-03-07
  • Large Shareholder at Xtera Communications Inc. (XCOM), 2016-10-13
  • Large Shareholder at Impinj Inc (PI), 2016-08-31
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-25
  • Director at Sage Therapeutics Inc. (SAGE), 2015-11-12
  • Large Shareholder at Adesto Technologies Corp (IOTS), 2015-11-04
  • Large Shareholder at Vbi Vaccines Inc. (VBIV), 2015-08-17
  • Other at Kythera Biopharmaceuticals Inc (KYTH), 2015-03-26
  • Large Shareholder, Director at Bellerophon Therapeutics Inc. (BLPH), 2015-02-24
  • Large Shareholder at Receptos Inc. (RCPT), 2014-05-15
  • Large Shareholder at Achaogen Inc (AKAO), 2014-03-17
  • Large Shareholder, Director at Fate Therapeutics Inc (FATE), 2013-10-07
  • Large Shareholder at Bluebird Bio Inc. (BLUE), 2013-06-26
  • Large Shareholder, Director at Neurogesx Inc (NGSX), 2012-06-12
  • Large Shareholder at Trubion Pharmaceuticals Inc (TRBN), 2010-11-01
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KRTX $16.00 100,000 Large Shareholder, Director 1,681,435 2019-07-02 Filing
KRTX $16.00 100,000 Large Shareholder, Director 1,681,437 2019-07-02 Filing
SYRS $12.50 400,000 Large Shareholder, Director 4,637,137 2016-07-06 Filing
BLPH $12.00 212,666 Large Shareholder, Director 965,660 2015-02-19 Filing
FATE $6.00 833,333 Large Shareholder, Director 2,473,188 2013-10-04 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AGIO $49.43 40 Director 0 2017-03-06 Filing
AGIO $52.15 400 Director 40 2017-03-03 Filing
AGIO $51.34 8,734 Director 440 2017-03-03 Filing
AGIO $50.69 31,425 Director 9,174 2017-03-03 Filing
AGIO $50.18 20,237 Director 40,599 2017-02-28 Filing